Drugmakers see booming demand for weight-loss drugs
Strong demand for Wegovy, Ozempic just scratching surface, says CEO of Novo Nordisk
Category: Healthcare
Medtech stocks rebound as hospital pressures ease
Shipping costs and chip shortages have eased as demand for elective surgeries has recovered
Weight loss drugs Ozempic, Wegovy may be right for investors
Celebrity endorsements helping build market potential, analysts say
Medtronic stumbles amid medtech recovery
Slowing growth in core businesses, plus recalls and bribery allegation have worried investors
Despite demand, headwinds slow telehealth uptake
Telehealth services remain popular but billing and regulatory challenges are slowing its growth.
Covid fatigue takes toll on vaccine makers
Demand for boosters falls as virus seen as something less to be feared than managed
Struggling Babylon Holdings eyes reverse stock split
With its shares down 93% since its IPO, the telehealth company may try a tactic which doesn’t usually work.
Recession resistant healthcare stocks offer stability and safety
Considered dull during the tech boom, these mature, global businesses are back in favour.
Selloff continues for telehealth IPO Babylon Holdings
UK-based firm has lost more than half of its value since its October IPO which raised money for US expansion.
Cautious medtech sees surgery rebound
Much delayed and needed elective surgeries are getting back on track as the latest wave of COVID-19 infections eases.
Adam Mayers 
You must be logged in to post a comment.